Bortezomib-based four-drug induction does induce a response in advanced relapsed ALL but cure remains elusive

Pediatr Blood Cancer. 2020 Mar;67(3):e28115. doi: 10.1002/pbc.28115. Epub 2019 Dec 9.

Authors

Yoav H Messinger¹, Bruce C Bostrom¹

Affiliation

¹ Children's Hospitals and Clinics of Minnesota, Pediatric Hematology-Oncology, Minneapolis, Minnesota.

PMID: 31820566
DOI: 10.1002/pbc.28115

No abstract available

Keywords: acute lymphoblastic leukemia; bortezomib; chemotherapy; children; refractory; relapse.

Publication types

Comment

MeSH terms

Asparaginase
Bortezomib
Child
Dexamethasone
Humans
Mitoxantrone*
Polyethylene Glycols
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Vincristine

Substances

Polyethylene Glycols
Vincristine
Bortezomib
pegaspargase
Dexamethasone
Mitoxantrone
Asparaginase